Xiao Xiao, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Published online: June 2001
DOI: 10.1038/npg.els.0000408
Adeno‐associated viruses are small, nonenveloped, single‐stranded viruses of the genus Dependovirus, family Parvoviridae. They are so named because their propagation depends upon the coinfection by an unrelated virus for essential helper functions.
Keywords: parvoviridae; AAV; episomal persistence; recombinant viral vector; vector production; gene therapy; rep proteins; hairpin transfer replication; site‐specific integration
|
Figure 1.
Electron microscopy of (a) adeno‐associated virus 2 (AAV2) and (b) its helper virus, adenovirus 2. Note the few empty AAV particles that lack viral DNA genome and are imaged like a ring. |
|
Figure 2.
The genome structure and gene products of adeno‐associated virus 2 (AAV2). ITR, inverted terminal repeat. |
|
Figure 3.
The latent and productive life cycles of adeno‐associated virus (AAV). Ad, adenovirus. |
|
Figure 4.
The terminal transfer model of linear adeno‐associated virus (AAV) DNA replication. The 3′ termini are indicated by an arrowhead, and newly synthesized DNA by dotted lines. |
|
Figure 5.
Adeno‐associated virus (AAV) vector production by the helper virus‐free, triple‐plasmid transfection method, where no adenovirus is used nor can it be generated. Three of the five essential adenovirus (Ad) helper genes are provided by the helper plasmid (VA RNA, E2 and E4), while the other two genes (E1A and E1B) are provided by the host 293 cells. ITR, inverted terminal repeat. |
|
Figure 6.
Efficient and long‐term gene transfer into mature muscle after direct injection of an adeno‐associated virus (AAV) vector that contains a β‐galactosidase gene from Escherichia coli. Transverse thin section of the vector‐injected mouse muscle showed blue‐coloured muscle cells across the entire area after X‐gal staining, which turned the β‐galactosidase‐positive cells blue. Magnification 40×. |
References
Atchinson RW, Castro BC and Hammon WMD (1965) Adenovirus‐associated defective virus particles. Science 149: 754–756.
Berns KI (1990) Parvoviridae and their replication In: Fields BN, Knipe DM, Chanock RM et al. (eds) Virology, 2nd edn, Vol 2. New York: Raven Press.
Cavalier‐Smith T (1974) Palindronic base sequences and replication of eukaryotic chromosome ends. Nature 250: 467–470.
Clark KR, Voulgaropoulou F, Fraley DM and Johnson PR (1995) Cell lines for the production of recombinant adeno‐associated virus. Human Gene Therapy 6: 1329–1341.
Conway JE, Rhys CM, Zolotukhin I et al. (1999) High‐titer recombinant adeno‐associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV‐2 Rep and Cap. Gene Therapy 6: 986–993.
Duan D, Sharma P, Yang J et al. (1998) Circular intermediates of recombinant adeno‐associated virus have defined structural characteristics responsible for long‐term episomal persistence in muscle tissue. Journal of Virology 72: 8568–8577.
Duan D, Yue Y, Yan Z, Yand J and Engelhardt JF (2000) Endosomal processing limits gene transfer to polarized airway epithelia by adeno‐associated virus. Journal of Clinical Investigation 105: 1573–1587.
Ferrari FK, Samulski T, Shenk T and Samulski RJ (1996) Second‐strand synthesis is a rate‐limiting step for efficient transduction by recombinant adeno‐associated virus vectors. Journal of Virology 70: 3227–3234.
Fisher KJ, Gao GP and Weitzman MD et al. (1996) Transduction with recombinant adeno‐associated virus for gene therapy is limited by leading‐strand synthesis. Journal of Virology 70: 520–532.
Flotte TR, Afione SA and Zeitlin PL (1994) Adeno‐associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. American Journal of Respiratory Cell and Molecular Biology 11: 517–521.
Flotte TR, Carter B, Conard C et al. (1996) A phase I study of an adeno‐associated virus‐CFTR gene vector in adult CF patients with mild lung disease. Human Gene Therapy 7: 1145–1159.
George‐Fries B, Biederlack S, Wolf J and zur Hausen H (1984) Analysis of proteins, helper dependence and seroepidemiology of a new human parvovirus. Virology 134: 64–71.
Hoggan MD, Blacklow NR and Rowe WP (1966) Studies of small DNA viruses found in various adenovirus preparations: physical, biological and immunological characteristics. Proceedings of the National Academy of Sciences of the United States of America 55: 1467–1474.
Im DS and Muzyczka N (1990) The AAV origin binding protein Rep68 is an ATP‐dependent site‐specific endonuclease with DNA helicase activity. Cell 61: 447–457.
Kaplitt MG, Leone P, Samulski RJ et al. (1994) Long‐term gene expression and phenotypic correction using adeno‐associated virus vectors in the mammalian brain. Nature Genetics 8: 148–154.
Kay MA, Manno CS, Ragni MV et al. (2000) Evidence for gene transfer and expression for factor IX in haemophilia B patients treated with an AAV vector. Nature Genetics 24: 257–261.
Kotin RM, Siniscalco M, Samulski RJ et al. (1990) Site‐specific integration by adeno‐associated virus. Proceedings of the National Academy of Sciences of the United States of America 87: 2211–2215.
Mayor HD, Drake S, Stahmann J and Mumford DM (1976) Antibodies to adeno‐associated satellite virus and herpes simplex in sera from cancer patients and normal adults. American Journal of Obstetrics and Gynecology 126: 100–104.
Samulski RJ, Chang LS and Shenk T (1989) Helper‐free stocks of recombinant adeno‐associated viruses: normal integration does not require viral gene expression. Journal of Virology 63: 3822–3828.
Samulski RJ, Zhu X, Xiao X et al. (1991) Targeted integration of adeno‐associated virus (AAV) into human chromosome 19. EMBO Journal 10: 3941–3950.
Smith RH and Kotin RM (1998) The Rep52 gene product of adeno‐associated virus is a DNA helicase with 3′ to 5′ polarity. Journal of Virology 72: 4874–4881.
Summerford C and Samulski RJ (1998) Membrane‐associated heparan sulfate proteoglycan is a receptor for adeno‐associated virus type 2 virions. Journal of Virology 72: 1438–1445.
Sun L, Li J and Xiao X (2000) Overcoming adeno‐associated virus vector size limitation through viral DNA heterodimerization. Nature Medicine 6: 599–602.
Xiao X, Li J and Samulski RJ (1998) Production of high‐titer recombinant adeno‐associated virus vectors in the absence of helper adenovirus. Journal of Virology 72: 2224–2232.
Xiao X, Li J and Samulski RJ (1996) Efficient long‐term gene transfer into muscle tissue of immunocompetent mice by adeno‐associated virus vector. Journal of Virology 70: 8098–8108.
Xiao X, Xiao W, Li J and Samulski RJ (1997) A novel 165 base‐pair terminal repeat sequence is the sole cis requirement for the adeno‐associated virus life cycle. Journal of Virology 71: 941–948.
Zolotukhin S, Byrne BJ, Mason E et al. (1999) Recombinant adeno‐associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 6: 973–985.
Further Reading
Berns KI and Giraud C (1996) Biology of adeno‐associated virus. Current Topics in Microbiology and Immunology 218: 1–23.
Muzyczka N (1992) Use of adeno‐associated virus as a general transduction vector for mammalian cells. Current Topics in Microbiology and Immunology 158: 97–129.
Samulski RJ, Sally M and Muzyczka N (1999) Adeno‐associated viral vectors. In: Friedmann T (ed.) Development of Human Gene Therapy, pp. 131–172. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
Tijssen P (ed.) (1990) Handbook of Parvoviruses. Boca Raton, FL: CRC Press.
* Required Field
Copyright © by John Wiley & Sons, Inc., or related companies. All rights reserved.
